<DOC>
	<DOCNO>NCT01280409</DOCNO>
	<brief_summary>The purpose study determine whether study drug metformin helpful reduce weight pregnancy woman gestational diabetes . This pilot study provide information well woman able take metformin postpartum , whether metformin increase weight loss , whether increased risk side effect new mother .</brief_summary>
	<brief_title>Metformin Postpartum GDM RCT Reduced Weight Retention</brief_title>
	<detailed_description>At 24-48 hour delivery , woman eligible participation approach consent study . Maternal weight measure 20ml maternal blood obtain ass glucose control lipid profile . Women counsel regard diet , exercise glucose control . Data include maternal demographic , clinical characteristic neonatal outcomes collect . At 3 week postpartum , research nurse contact subject via telephone call inquire adverse side effect , ability take prescribed medication ( metformin placebo ) , answer question study . At 6 week postpartum , maternal weight measure , blood obtain side effect evaluate . Finally , satisfaction survey complete .</detailed_description>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Postpartum woman delivery great 34 week pregnancy Between age 18 49 year Women diagnosis gestational diabetes mellitus ( either treat insulin , oral hypoglycemic agent dietcontrolled ) 24 week recent pregnancy base confirmatory 3 hour glucola test ( base either Carpenter Coustan 's Diabetes Task Force criterion ) woman pregestational diabetes mellitus ( either Type I Type II DM ) woman unable tolerate metformin base patient history woman discharge hom eon insulin oral hypoglycemic agent immediate postpartum period woman BMI &lt; 25 kg/mÂ²</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>